TG Therapeutics Reports Encouraging Early Phase 1 Cell Therapy Results
The company reported encouraging early results from a Phase 1 trial of its experimental cell therapy in patients with progressive multiple sclerosis.
The company reported encouraging early results from a Phase 1 trial of its experimental cell therapy in patients with progressive multiple sclerosis.